Cardiovascular Clinic, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland.
Nutrients. 2023 Oct 23;15(20):4487. doi: 10.3390/nu15204487.
Cardiovascular disease (CVD) continues to be the leading cause of death in European men. Atherosclerosis and its clinical consequence, chronic coronary syndrome (CCS), comprise two main elements: dysfunction of lipoprotein metabolism and an important inflammatory component that contributes to the development of complications, including acute coronary syndrome (ACS). Measures of both components are combined in a composite marker called monocyte-to-HDL ratio (MHR). Vitamin D was previously described to influence inflammation processes, and its deficiency influences CVD risk factors. This research describes the differences in MHR and total serum 25-hydroxyvitamin D (25(OH)D) concentration between male patients with different diagnoses of CCS and the correlation between 25(OH)D and MHR in this group. Significant differences were observed between ACS and CCS patients in 25(OH)D and MHR-the highest HDL and serum 25(OH)D concentrations were observed in patients with CCS, whereas the highest value of MHR was observed in patients with STEMI. A significant correlation was observed between 25(OH)D, HDL, and MHR. Due to the significant but small nominal difference in MHR values between groups of patients diagnosed with ACS and CCS, and the possible influence of age and hyperlipidemia status on the differences in vitamin D levels in these groups, this subject requires further well-designed research. The suggested bidirectional relationship between MHR and 25(OH)D and the role of MHR as a predictor of vitamin D status in the body also needs to be verified.
心血管疾病(CVD)仍然是欧洲男性的主要死因。动脉粥样硬化及其临床后果,慢性冠状动脉综合征(CCS),包括两个主要元素:脂蛋白代谢功能障碍和一个重要的炎症成分,有助于发展并发症,包括急性冠状动脉综合征(ACS)。这两个组成部分的测量结果结合在一个叫做单核细胞与高密度脂蛋白比值(MHR)的综合标志物中。维生素 D 以前被描述为影响炎症过程,其缺乏会影响 CVD 危险因素。本研究描述了不同诊断为 CCS 的男性患者之间 MHR 和总血清 25-羟维生素 D(25(OH)D)浓度的差异,以及该组中 25(OH)D 和 MHR 之间的相关性。在 ACS 和 CCS 患者中观察到 25(OH)D 和 MHR 之间存在显著差异——CCS 患者的 HDL 和血清 25(OH)D 浓度最高,而 STEMI 患者的 MHR 值最高。观察到 25(OH)D、HDL 和 MHR 之间存在显著相关性。由于 ACS 和 CCS 诊断组之间的 MHR 值存在显著但微小的名义差异,以及年龄和高血脂状态对这些组中维生素 D 水平差异的可能影响,因此需要进一步进行精心设计的研究。还需要验证 MHR 和 25(OH)D 之间的双向关系以及 MHR 作为体内维生素 D 状态预测因子的作用。